Document is current
Any future updates will be listed below
-
Authors
Zhao, Xinju
Karaboyas, Angelo
Gan, Liangying
Hou, Fan Fan
Liang, Xinling
Chen, Xiaonong
Chen, Yuqing
Ni, Zhaohui
Pecoits-Filho, Roberto
Zuo, Li
-
Funding
Funding for this research was provided by:
Peking University People’s Hospital Scientific Research Development Funds (RDJ 2022- 39)
Beijing Natural Science Foundation (7222201)
- License Information
-
More Information
Article History
Received: 13 March 2024
Accepted: 24 October 2024
First Online: 4 November 2024
Declarations
:
: RPF is an employee of Arbor Research Collaborative for Health, which receives global support for the ongoing DOPPS Programs (provided without restriction on publications by a variety of funders; for details see https://www.dopps.org/AboutUs/Support.aspx) and has received research grants from Fresenius Medical Care; consulting fees (paid to the employer) from AstraZeneca, Akebia, Novo Nordisk and Fresenius, Bayer, Boehringer, Novo Nordisk and Akebia. Other authors declare that they have no competing interests.
: The study was approved by the Ethics Committee of Peking University People’s Hospital (ethical approval number: 2018PHB028-01). Other participating sub-centers also obtain ethics committee approval documents prior to the start of clinical trials. All patients signed the written informed consent.
